Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
GRNA TARGETING SEQUENCE FOR SPECIFICALLY TARGETING HUMAN NGL GENE AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/000458
Kind Code:
A1
Abstract:
Provided is a gRNA targeting sequence for specifically targeting human NGL gene, which has a nucleotide sequence of 5'-AGCTGAGATTCCCCTCCATT-3'. Knockout of the NGL gene is achieved after introducing the gRNA and the CRISPR system into the target cell by the Cas9 carrier.

Inventors:
MAO JIYAN (CN)
Application Number:
PCT/CN2018/093868
Publication Date:
January 02, 2020
Filing Date:
June 29, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHENZHEN BIOCAN TECH CO LTD (CN)
International Classes:
C12N15/113; C12N15/85
Foreign References:
CN106434663A2017-02-22
CN107446045A2017-12-08
CN101418293A2009-04-29
CN104232573A2014-12-24
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: GRNA TARGETING SEQUENCE THAT SPECIFICALLY TARGETS HUMAN KAT13D GENE AND USE THEREOF

Next Patent: CRISPR/CAS9-TARGETED KNOCKOUT OF HUMAN TP55 GENE AND SPECIFIC GRNA THEREFOR